Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

COPS6 decreases the amount of CTNNB1. 3 / 3

| 3

➶

reach

"Furthermore, CSN6 increased the ubiquitination level of beta-Trcp and reduced the ubiquitination level of beta-catenin (XREF_FIG)."

26267535

➶

reach

"Furthermore, CSN6 increased the ubiquitination level of beta-Trcp and reduced the ubiquitination level of beta-catenin."

26267535

➶

reach

"Congruently, CSN6 knockdown xenograft tumors had elevated beta-Trcp and diminished beta-catenin expression and a slower growth rate."

26267535

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

COPS6 decreases the amount of CTNNB1. 3 / 3

Our Sources:

Databases

Reading